POORNIMA BOND: Open Payments
NPI 1285343921 · TRUMBULL, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,697 in 239 payments from 21 companies in 2025. Trend: 2023 $2,401 · 2024 $4,095 · 2025 $4,697
Food & beverage: $4,697
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $646 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $416 |
| Corium, LLC | 21 | $394 |
| Neurocrine BioSciences, Inc. | 14 | $381 |
| E.R. Squibb & Sons, L.L.C. | 21 | $334 |
| Teva Pharmaceuticals USA, Inc. | 17 | $323 |
| Vanda Pharmaceuticals Inc. | 16 | $323 |
| Alkermes, Inc. | 12 | $280 |
| Lundbeck LLC | 12 | $268 |
| Tris Pharma Inc | 17 | $248 |
Products named: VRAYLAR, CAPLYTA, Azstarys, INGREZZA, COBENFY, FANAPT, REXULTI, SUBLOCADE.
Industry payments across CT — which companies pay providers there.
